advanced search

Welcome: Guest

log in

Molecular Diagnostics Market: Trends and Opportunities

Publication Date July 2009
Publisher Koncept Analytics
Product Type Report
Pages 43
ISBN Number not applicable
Product Code KOA04821
Buy this product or for assistance call +44 20 7060 7474

Summary

Molecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing market, driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics (IVD) market, molecular diagnostics market is one of the two growth drivers of the IVD industry.

In the decision making process of healthcare experts, diagnostics tests have a major influence. Diagnostics tests are a very small percentage cost of medical expenditures but generally accounts for 60-70% of all treatment decisions. And with the advent of molecular diagnostics, there is a growing focus on diagnostics for early detection of diseases.

Molecular diagnostics holds immense business potential as it is based on the intention of identifying viruses and infectious diseases more accurately at an earlier stage than currently possible. Molecular diagnostics has also emerged as a potential business opportunity as diagnostics businesses generally fetch higher returns of investment than pharmaceutical and other biotech businesses.

The molecular diagnostics industry is growing on the path of continuous innovation and changing technological base and this is creating new opportunities and applications. The major factors that will drive the growth of this industry includes the increasing incidences of various chronic diseases, increasing number of cases of hepatitis B and tuberculosis and the availability of various molecular diagnostics tests. Molecular diagnostics or MDx is the fastest growing segment of the IVD market, also because of the innovation in the industry resulting in the advent of new technologies for genetic testing, faster screening and more precise detection.

The report titled ""Molecular Diagnostics Industry: Trends and Opportunities"" analyzes the molecular diagnostics segment of IVD industry. The study explores the potential business opportunities that exist in the molecular diagnostics industry. Further, factors that are driving the growth of the industry have been assessed. Also, major industry trends have been outlined. The report analyzes the level of competition in the molecular diagnostics industry and also profiles the leading players underlining their sales and business strategies.

Further, we have predicted the future growth of the molecular diagnostics industry by combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings. We employed various significant variables that have an impact on this industry and created regression models with SPSS to determine the future direction of the industry.

Content

  • 1. Molecular Diagnostics: An Overview
    • 1.1 An Introduction to Molecular Diagnostics
    • 1.2 Industry Background
    • 1.3 IVD Market: An Analysis
  • 2. Molecular Diagnostics: Market Analysis
    • 2.1 Market Size and Growth
    • 2.2 Segment Analysis
  • 3. Market Opportunities
    • HPV - a potential growth opportunity
    • India - an emerging market for molecular diagnostics
    • HCV segment - a major contributor to MDx growth
  • 4. Growth Drivers
    • High returns on investment (ROI)
    • Growth in US cancer molecular diagnostics market
    • Macro-environment favoring genetic testing industry
    • Applied Testing Market
    • Growth potential in sepsis diagnosis
  • 5. Market Trends
    • Higher price of MDx compared to traditional tests
    • Growth of automation solutions
    • Leading molecular tests conducted in the US
    • Reimbursement for molecular diagnostics tests?
    • Blood screening and STD market
    • Multiplex Platforms
  • 6. Competition
  • 7. Company Analysis
    • 7.1 Roche Diagnostics
      • Company Description
      • Sales Analysis
      • Business Strategies
    • 7.2 Qiagen
      • Company Description
      • Sales Analysis
      • Business strategies
    • 7.3 Abbott
      • Company Description
      • Sales Analysis
      • Business Strategies
    • 7.4 GenProbe
      • Company Description
      • Sales Analysis
      • Business Strategies
  • 8. Market Outlook
    • 8.1 Market Forecast
    • 8.2 Forecast Methodology
      • 8.2.1 Dependent and Independent Variables
      • 8.2.2 Correlation Analysis
      • 8.2.3 Regression Analysis
  • List of Figures
    • Figure 1.1: In Vitro Diagnostic (IVD) Segments
    • Figure 1.2: Global IVD Market Size - 2006 - 2008 & 2012E
    • Figure 1.3: IVD Market - Region-wise Breakup (2008)
    • Figure 1.4: IVD Market - Segment Breakup (2008)
    • Figure 1.5: Segment-wise Global IVD Market Growth, 2007-2012E
    • Figure 1.6: CAGR of Global IVD Market segments, 2004-2009E
    • Figure 2.1: Global Molecular Diagnostics Market Size: 2005 - 2008
    • Figure 2.2: Molecular Diagnostics Segment Breakup-Value: 2008
    • Figure 2.3: Molecular Diagnostics Segment Breakup-Percentage: 2008
    • Figure 3.1: Global HPV market Size (Value): 2003-2008
    • Figure 3.2: Global HPV market Size (Value) Forecast: 2009-2015
    • Figure 3.3: Global HPV market Potential by Region
    • Figure 3.4: Global HPV screening market by region - Penetrated and un-penetrated
    • Figure 3.5: Cancer: Incidence & Deaths - US (2008)
    • Figure 3.6: Indian molecular diagnostics market: 2007 - 2009
    • Figure 4.1: US Cancer Molecular Diagnostics Market: 2006-2012
    • Figure 4.2: Incidence and mortality - severe sepsis
    • Figure 4.3: Sales potential of sepsis tests
    • Figure 5.1: Molecular diagnostics versus traditional tests - Cost comparison
    • Figure 5.2: Top-10 Molecular Tests - US
    • Figure 6.1: Market share of leading Players - Global IVD Market: 2008
    • Figure 6.2: Global Molecular Diagnostics Market Share: Companies - 2008
    • Figure 6.3: US Molecular Diagnostics Market Share: Companies-2007 vs. 2008
    • Figure 7.1: Roche Diagnostics - Sales by sub-segment: 2008
    • Figure 7.2: Qiagen - Sales by product group (2008)
    • Figure 7.3: Abbott - Sales by business segment (2008)
    • Figure 7.4: GenProbe - Sales: Clinical Diagnostics & Blood Screening: 2006-08
    • Figure 8.1: Global Molecular Diagnostics Market Forecast: 2000 - 2010
  • List of Tables
    • Table 1.1: IVD market by Technology
    • Table 8.1 Dependent & Independent Variables (2002- 2008)
    • Table 8.2 Correlation Matrix
    • Table 8.3 Model Summary - Coefficient of Determination
    • Table 8.4 Regression Coefficients Output
Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)

Industry Events

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>